A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

Every step of the way, Rose Booker, formally of the Durham Catholic District School Board, has worked tirelessly to make sure ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

Other pharmaceutical players such as Roche, Amgen, Pfizer, AstraZeneca and Boehringer also have obesity drugs in the pipeline ...

Dr Ilomäki reported receiving grants from Amgen, National Health and Medical Research Council, Dementia Australia Research Foundation, Yulgilbar Foundation, National Breast Cancer Foundation, Medical ...

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us ...